Patent · US Active

Progesterone antagonists

US8673968B2 · kind B2 · utility

1Cited by

3References

2Claims

0Family size

Assignee

Evestra, Inc. · US

Inventors

Klaus Nickisch · Berlin, DE
James W. Cessac · Floresville, US
Kesavaram Narkunan · San Antonio, US
Baishakhi Das · San Antonio, US

Key dates

Filing date	Mar 29, 2010
Grant date	Mar 18, 2014
Priority date	—
Expiry date	Mar 23, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J43/003
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Described herein are compounds which exhibit progesterone antagonistic effects and methods of treating cancer using such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.